[Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002648:Child; D003872:Dermatitis / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010648:Phenylacetates / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D006877:Hydroxamic Acids; D009824:Ointments; D010648:Phenylacetates
L'activité thérapeutique d'un nouveau medicament non steroidien (bufexamac) dans le traitement des affections dermatologiques inflammatoires. Etude clinique en double insu.